No image

MSH2 IHC pharmDx (Dako Omnis)

Details

Device typeMSH2 antigen IVD, antibody: One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of MSH2 antigen in a clinical specimen.

FDA categoryImmunohistochemistry test, DNA mismatch repair (MMR) Protein assay

Device ID05700575005220

MRI safetyLabeling does not contain MRI Safety Information

Total Volume12 Milliliter

Contact

Phone+1-800-227-9770

EmailGlobal.RA@agilent.com

Related products

Product	Model	Company	Device type
MLH1 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.MLH1 antigen IVD, antibody	GE079	Agilent Technologies, Inc.	MLH1 antigen IVD, antibody
PMS2 IHC pharmDx (Dako Omnis)Agilent Technologies, Inc.Postmeiotic segregation increased 2 (PMS2) IVD, antibody	GE087	Agilent Technologies, Inc.	Postmeiotic segregation increased 2 (PMS2) IVD, antibody
MMR Negative Control Reagent, Mouse (Dako Omnis)Agilent Technologies, Inc.Negative control immunoglobulin IVD	GE101	Agilent Technologies, Inc.	Negative control immunoglobulin IVD
Ki-67 IHC MIB-1 pharmDx (Dako Omnis)Agilent Technologies, Inc.Ki67 antigen IVD, kit, enzyme immunohistochemistry	GE020	Agilent Technologies, Inc.	Ki67 antigen IVD, kit, enzyme immunohistochemistry